Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
EV/Core EBITDA

    Back to All Ratios
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9811.9513.0515.315.81

What is the latest EV/Core EBITDA ratio of AARTI DRUGS ?

The latest EV/Core EBITDA ratio of AARTI DRUGS is 13.98 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202413.98
Mar202311.95
Mar202213.05
Mar202115.31
Mar20205.81

How is EV/Core EBITDA of AARTI DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.98
16.99
Mar2023 11.95
-8.43
Mar2022 13.05
-14.76
Mar2021 15.31
163.51
Mar2020 5.81 -

Other Financial Ratios of AARTI DRUGS


Compare EV/Core EBITDA ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,708.8 Cr 8.9% 15.4% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,667.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹180,131.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,745.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,603.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,429.0 Cr 0.7% -3.8% -7.3% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

8.9%

15.4%

-3.2%

SENSEX

-1.1%

0.8%

2.2%


You may also like the below Video Courses